喘息における粘膜機能不全を防ぐために,AAV媒介のMUC5AC siRNA配送
Sahana Kumar1, Maria Corkran2, Yahya Cheema1
1Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA.
Gene therapy
|August 23, 2025
まとめ
アデノ関連ウイルス6型 (AAV6) 遺伝子治療は,喘息における重要な粘液成分であるMUC5ACを減少させることができます. このアプローチは,肺疾患における呼吸道クリアランスの回復と粘液機能障害の治療の可能性を示しています.
科学分野:
- 肺医学
- 遺伝子療法
- 呼吸器細胞生物学
背景:
- 肺内の粘液は主にムシン5B (MUC5B) とムシン5AC (MUC5AC) で構成されています.
- 喘息はMUC5ACの産生が増加し,粘膜clearance (MCC) が低下し,粘液栓が形成される.
- MUC5ACは,喘息に関連する呼吸道阻害の管理のための潜在的な治療目標です.
研究 の 目的:
- 呼吸道上皮細胞におけるMUC5AC発現を減少させる遺伝子配送ベクターとしてアデノ関連ウイルス6型 (AAV6) を調査する.
- MUC5ACを抑制し,MCCを回復させるためのAAV6媒介のsiRNA配送の有効性を評価する.
主な方法:
- アデノ関連ウイルスの血清型6 (AAV6) は,MUC5ACを標的とするsiRNAを呼吸道上皮細胞にインビトロおよびインビボで送達するために使用されました.
- 粘液分泌コップレット細胞におけるトランスデュークション効率とトランスゲン発現を評価した.
- AAV6が粘液の障壁を通過する能力を評価するために,複数の粒子の追跡分析が使用されました.
- IL-13が発現する前に,ヒト呼吸道上皮細胞培養 (HAE) をAAV6- MUC5AC siRNAで処理し,MUC5ACの発現とMCCを評価した.
主要な成果:
- AAV6は呼吸道上皮細胞を in vitro および in vivo で効果的に変換し,コップセルで高い発現を示した.
- AAV6は正常な粘液とMUC5AC濃縮された粘液の両方に浸透する能力を示した.
- AAV6- MUC5AC siRNAによる治療は,IL- 13刺激されたHAE培養におけるMUC5AC mRNAとタンパク質のレベルを有意に低下させた.
- AAV6- MUC5AC siRNA治療は,IL-13刺激されたHAE培養で正常な粘膜輸送を維持した.
結論:
- AAV6は,粘液を生成するコップレット細胞を含む,呼吸道上皮細胞への遺伝子伝達のための効果的なウイルスベクターとして機能する.
- 吸入によるAAV6基因治療は,MUC5AC過剰発現を抑制する.
- このアプローチは,MUC5ACをターゲットにすることで,喘息における正常な呼吸道クリアランスの機能を回復させるのに有望である.
関連する概念動画
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
452
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
452
01:20Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:24Antiasthma Drugs: Methylxanthines
397
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
397
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K